Effect of high dose of telmisartan for hyper molucular adiponectin and insulin resistance in patients with type 2 diabetes complicated with hypertension.
Phase of Trial: Phase III
Latest Information Update: 20 Jul 2012
At a glance
- Drugs Telmisartan (Primary) ; Amlodipine
- Indications Hypertension in diabetes; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 20 Jul 2012 Primary endpoint 'Adiponectin-levels' has been met according to results published in Advances in Therapy; at 3 months, telmisartan 80 mg/day significantly increased HMW adiponectin levels from baseline compared with telmisartan 40 mg/day + amlodipine.
- 20 Jul 2012 Results published in Advances in Therapy.
- 11 Feb 2012 New trial record